Evidence map›Paper›PMID 25275463›Full record

ArticlePloS one2014

Cysteine transport through excitatory amino acid transporter 3 (EAAT3).

Spencer D Watts, Delany Torres-Salazar, Christopher B Divito, Susan G Amara

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.5field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Structural basis of excitatory amino acid transporter 3 substrate recognition.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Antioxidants (Basel, Switzerland) · 2022
    Review
  13. Review
  14. Protective Role of Glutathione in the Hippocampus after Brain Ischemia.International journal of molecular sciences · 2021
    Review
  15. The Role of Non-Coding RNAs in the Neuroprotective Effects of Glutathione.International journal of molecular sciences · 2021
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Spencer D WattsCenter for Neuroscience, Department of Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Delany Torres-SalazarLaboratory of Cellular and Molecular Neurobiology, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, United States of America.
Christopher B DivitoCenter for Neuroscience, Department of Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Susan G AmaraCenter for Neuroscience, Department of Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America; Laboratory of Cellular and Molecular Neurobiology, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, United States of America.
University of Pittsburgh · USNational Institute of Mental Health · USNational Institutes of Health · US

Funding

Molecular Studies of Human CNS Glutamate TransportersR01MH080726 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TORRES, GONZALO E. · 2007 to 2013
$2.1M
NIMH NIH HHS MH080726NIMH NIH HHS R01 MH080726
6 · The paper itself

Abstract

Excitatory amino acid transporters (EAATs) limit glutamatergic signaling and maintain extracellular glutamate concentrations below neurotoxic levels. Of the five known EAAT isoforms (EAATs 1-5), only the neuronal isoform, EAAT3 (EAAC1), can efficiently transport the uncharged amino acid L-cysteine. EAAT3-mediated cysteine transport has been proposed to be a primary mechanism used by neurons to obtain cysteine for the synthesis of glutathione, a key molecule in preventing oxidative stress and neuronal toxicity. The molecular mechanisms underlying the selective transport of cysteine by EAAT3 have not been elucidated. Here we propose that the transport of cysteine through EAAT3 requires formation of the thiolate form of cysteine in the binding site. Using Xenopus oocytes and HEK293 cells expressing EAAT2 and EAAT3, we assessed the transport kinetics of different substrates and measured transporter-associated currents electrophysiologically. Our results show that L-selenocysteine, a cysteine analog that forms a negatively-charged selenolate ion at physiological pH, is efficiently transported by EAATs 1-3 and has a much higher apparent affinity for transport when compared to cysteine. Using a membrane tethered GFP variant to monitor intracellular pH changes associated with transport activity, we observed that transport of either L-glutamate or L-selenocysteine by EAAT3 decreased intracellular pH, whereas transport of cysteine resulted in cytoplasmic alkalinization. No change in pH was observed when cysteine was applied to cells expressing EAAT2, which displays negligible transport of cysteine. Under conditions that favor release of intracellular substrates through EAAT3 we observed release of labeled intracellular glutamate but did not detect cysteine release. Our results support a model whereby cysteine transport through EAAT3 is facilitated through cysteine de-protonation and that once inside, the thiolate is rapidly re-protonated. Moreover, these findings suggest that cysteine transport is predominantly unidirectional and that reverse transport does not contribute to depletion of intracellular cysteine pools.

Indexed as

AnimalsCysteineExcitatory Amino Acid Transporter 2Excitatory Amino Acid Transporter 3Glutamic AcidHEK293 CellsHumansHydrogen-Ion ConcentrationOocytesSelenocysteineXenopusCysteineExcitatory Amino Acid Transporter 2Excitatory Amino Acid Transporter 3Glutamic AcidSelenocysteine

Identifiers

PMID25275463
PMCPMC4183567
OpenAlexW1964948381

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.